Once-weekly Semaglutide 2.0 mg Bests 1.0 mg Dose for A1c, Weight Reduction
November 18, 2020

Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.

Pharmacotherapy for Obesity Should Begin in Primary Care
November 05, 2020

Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.

Statin Use Lowers Mortality Among Patients with Diabetes Hospitalized with COVID-19
November 04, 2020

Adults with diabetes admitted to a New York City hospital with COVID-19 had a lower mortality risk if they received a statin, a new study found.

November 04, 2020

Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.

Finerenone Slows Renal Decline, Improves CV Outcomes in FIDELIO-DKD
October 23, 2020

The investigational mineralocorticoid receptor antagonist slowed progression to renal failure by 18% and reduced the composite cardiovascular outcome by 14%, authors report.

DPP-4 Inhibitor Found to Boost Survival in T2D Patients with COVID-19
October 06, 2020

According to a new study, adults with T2D who were hospitalized with COVID-19 in northern Italy had a lower mortality rate when treated with sitagliptin.

Patients with T2D at Greater Risk for Vascular than Other Dementias
September 24, 2020

The association of vascular dementia with T2D is stronger than that of nonvascular or Alzheimer dementia, according to a study presented at EASD.

FDA Puts Empagliflozin on Fast Track for Reduced Post-MI All-cause Mortality
September 17, 2020

Empagliflozin is now in FDA fast-track development for prevention of hospitalization for HF and reduced all-cause mortality in patients, with/without diabetes, post-AMI.

Weight Loss Shown to be Strongest Predictor of Type 2 Diabetes Remission
September 09, 2020

A new research article showed that after 1 year of weight loss intervention, 46% of patients with type 2 diabetes achieved remission.

Metabolic Effects Comparable with Roux-en-Y vs Diet in Type 2 Diabetes
August 26, 2020

In patients with obesity and type 2 diabetes, metabolic improvements were similar after weight loss induced by surgery or a low-calorie diet.